Springhill Fund Asset Management’s Summit Therapeutics SMMT Stock Holding History

Springhill Fund Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-124,307	Closed	-$2.4M	–	15
2025 Q1	$2.4M	Buy	+124,307	New	+$2.49M	11.49%	2

Other funds holding SMMT

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Springhill Fund Asset Management's SMMT Position: Q2 2025 in Review

Springhill Fund Asset Management sold out of Summit Therapeutics (SMMT) in Q2 2025, closing a stake of 124,307 shares — an estimated $2.4M sold.

Springhill Fund Asset Management first reported a position in SMMT in Q1 2025 and held it in 1 quarter. The position peaked at $2.4M in Q1 2025. 238 funds tracked by Wall St. Rank hold SMMT as of Q2 2025.

Springhill Fund Asset Management reported no remaining Summit Therapeutics position as of Q2 2025 after selling out during the quarter.
Springhill Fund Asset Management sold 124,307 Summit Therapeutics shares in Q2 2025, an estimated $2.4M.
Springhill Fund Asset Management first reported a position in Summit Therapeutics in Q1 2025 and held it in 1 quarter.
Springhill Fund Asset Management's Summit Therapeutics position peaked at $2.4M in Q1 2025.
238 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2025.

Based on Springhill Fund Asset Management's 13F filing for Q2 2025.